The influence of major depressive disorders on neurocognitive function among adults living with HIV/AIDS in a regional referral hospital in Dodoma, Tanzania
Authors:
- 22 November 2021
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 27 (1) , 58-67
Abstract
Objective: To determine the influence of major depressive disorders (MDD) on the cognitive function of adults living with HIV and the prevalence of neurocognitive impairment and major depressive disorders.Methods: The study was a cross‐sectional design conducted in a referral hospital in Dodoma region central Tanzania, with a sample of 397 participants attained through systematic sampling. Neurocognitive impairment was assessed by Montreal Cognitive Assessment (MoCA), while MDD was assessed using Mini International Neuropsychiatric Interview (M.I.N.I). Two‐sample independent t‐tests were done to compute the significance of the mean change of MoCA score between those with or without MDD. Univariate and multivariate ordinal logistic regression models were computed to determine the association between MDD and neurocognitive impairment across all cognitive domains.Results: Of 397 recruited participants, 266 (66.00%) met the criteria for neurocognitive disorder and 22 (5.51%) had major depressive disorder. Participants with MDD performed significantly poorer on cognitive testing than those without MDD (mean difference = 3.74, p‐value = 0.0009). Under univariate ordinal regression, impairments in the particular domains of visuospatial‐executive function, attention, language, abstraction and orientation were significantly associated with MDD and abstraction (AOR: 3.922, 95% CI: 1.546–9.947, p = 0.0004) remained significant under multivariable regression.Conclusion: Major depressive disorder may negatively influence neurocognitive performance in both severity and pattern of presentation. Routine screening for depressive symptoms in HIV care can be beneficial for the overall patient's outcome. Systematic and well‐designed studies in the area are crucial for understanding the interaction of neuropsychiatric disorders in the HIV population.Keywords
Funding Information
- National Institutes of Health (D43TW009775)
This publication has 50 references indexed in Scilit:
- Prevalence and risk factors of major depressive disorder in HIV/AIDS as seen in semi-urban Entebbe district, UgandaBMC Psychiatry, 2011
- Increased Activity Imbalance in Fronto-Subcortical Circuits in Adolescents with Major DepressionPLOS ONE, 2011
- Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment ResponseNeuropsychopharmacology, 2010
- Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in UgandaBMC Psychiatry, 2010
- Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gapAnnals of Neurology, 2010
- Synchronized Activity between the Ventral Hippocampus and the Medial Prefrontal Cortex during AnxietyNeuron, 2010
- Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapyHIV Medicine, 2009
- Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stressJournal of Neurology, Neurosurgery & Psychiatry, 2007
- Structural and functional plasticity of the human brain in posttraumatic stress disorder2007
- Psychiatric disorders in HIV-positive individuals in urban UgandaPsychiatric Bulletin, 2005